Observational studyBMC pregnancy and childbirth2026
Maternal perinatal vulnerability and its influencing factors in different stages.
Observational study in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Maternal Vulnerability Indicators Derived from Free-Text Clinical Documentation in Adolescent Pregnancy.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPerinatal is a special and critical period in female life, maternal in the perinatal vulnerable to various physiological, psychological and social stress, perinatal vulnerability rate is higher, seriously affect the physical and mental health, existing research pay more attention to a single stage, and more qualitative research, the lack of cross-stage comparison based on the same cohort, focus on perinatal vulnerability, help to reduce the risk of maternal and infant adverse outcomes.
objectiveTo explore the differences in perinatal vulnerability between 28 and 42 weeks and 1 postpartum.
methodsThis study was designed as a repeated-measure observational investigation. A convenience sample of 180 pregnant women receiving regular antenatal care or hospitalized in the obstetrics department of a tertiary hospital in Shandong from January to April 2025 was recruited. Data were collected at two time points (28–42 weeks of gestation and 1 week postpartum) using a general information questionnaire, the Visual Analogue Scale, the Fatigue Scale−14, the Personal Mastery Scale, and the Family APGAR Index. Data analysis was performed with SPSS 25.0.
resultsA total of 178 valid questionnaires were collected (effective response rate:98.9%). Perinatal vulnerability scores at one week postpartum (6.79 ± 1.63) were significantly higher than those at 28–42 weeks of gestation (6.43 ± 1.68) (P < 0.05). At both time points, fatigue was positively correlated with vulnerability (T1:r = 0.290; T2:r = 0.250, P < 0.01), while personal mastery and family care were negatively correlated with vulnerability (P < 0.05). Multiple linear regression indicated that the main influencing factors for vulnerability at 28–42 weeks of gestation included education level, monthly household income, history of adverse pregnancy outcomes, parity, fatigue, personal mastery, and family care (R²=0.280, F = 8.234, P < 0.001). At one week postpartum, the main influencing factors were place of residence, employment status, monthly household income, fatigue, personal mastery, and family care (R² =0.298, F = 8.956, P < 0.001).
conclusionPerinatal vulnerability escalates postpartum, with stage-specific risk factors. Tailored interventions addressing socio-demographic, psychological, and social support factors are essential to mitigate vulnerability and enhance maternal-infant outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.